Frazier Management’s Allena Pharmaceuticals ALNA Stock Holding History

Frazier Management’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,019,288	Closed	-$236K	–	2
2022 Q1	$236K	Sell	1,019,288 -632,069	-38%	-$262K	11.87%	2
2021 Q4	$978K	Sell	1,651,357 -1,679,016	-50%	-$1.31M	0.08%	42
2021 Q3	$3M	Hold	3,330,373	–	–	0.24%	35
2021 Q2	$4.33M	Hold	3,330,373	–	–	0.4%	28
2021 Q1	$4.63M	Hold	3,330,373	–	–	0.37%	30
2020 Q4	$4.26M	Hold	3,330,373	–	–	0.33%	28
2020 Q3	$4.93M	Hold	3,330,373	–	–	0.44%	20
2020 Q2	$5.26M	Hold	3,330,373	–	–	0.46%	19
2020 Q1	$3.21M	Hold	3,330,373	–	–	0.36%	19
2019 Q4	$9.09M	Hold	3,330,373	–	–	1.52%	12
2019 Q3	$13.1M	Hold	3,330,373	–	–	4.1%	8
2019 Q2	$13.6M	Hold	3,330,373	–	–	3.47%	8
2019 Q1	$23.4M	Hold	3,330,373	–	–	5.63%	5
2018 Q4	$18.2M	Hold	3,330,373	–	–	4.68%	7
2018 Q3	$35.8M	Hold	3,330,373	–	–	6.55%	3
2018 Q2	$43.4M	Hold	3,330,373	–	–	8.99%	4
2018 Q1	$36.7M	Hold	3,330,373	–	–	6.09%	5
2017 Q4	$33.5M	Buy	+3,330,373	New	+$41M	5.43%	5

Other funds holding ALNA

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Frazier Management's ALNA Position: Q2 2022 in Review

Frazier Management sold out of Allena Pharmaceuticals (ALNA) in Q2 2022, closing a stake of 1,019,288 shares — an estimated $236K sold.

Frazier Management first reported a position in ALNA in Q4 2017 and held it in 18 quarters. The position peaked at $43.4M in Q2 2018. 25 funds tracked by Wall St. Rank hold ALNA as of Q2 2022.

Frazier Management reported no remaining Allena Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Frazier Management sold 1,019,288 Allena Pharmaceuticals shares in Q2 2022, an estimated $236K.
Frazier Management first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 18 quarters.
Frazier Management's Allena Pharmaceuticals position peaked at $43.4M in Q2 2018.
25 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2022.

Based on Frazier Management's 13F filing for Q2 2022, filed 10 Aug 2022.